Synthetic cellular IL-1B is rapidly becoming a critical resource for researchers across several fields. This carefully manufactured form of interleukin-1 beta offers upsides over endogenously occurring IL-1B, like https://thefairlist.com/story11775333/engineered-human-interleukin-1-beta-a-powerful-instrument-in-investigation